Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by bigwalleyeon Jun 29, 2010 8:00am
345 Views
Post# 17229756

RE: RE: RE: Question?

RE: RE: RE: Question?If you were in charge of this thing would you just sit and wait for months??? It is worth more right now then if it doesn't make it into phase 3 in Oct. If they could get an offer which is selling the patent for a tidy sum and getting an extra incentive if they can help it get to phase three and a small royalty if it went to market??
If I was CEO I'd leave all the doors open to cash coming in... soon. Nobody here is invested in a patent SSS is a company that needs to keep reinventing itself to survive.

Food for thought ...JMO
Bullboard Posts